Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: A review

Andrologia

Volumn 46, Issue 7, 2014, Pages 791-795

  Asscheman, H ^a   T'Sjoen, G ^b   Lemaire, A ^a   Mas, M ^c   Meriggiola, M C ^d   Mueller, A ^e   Kuhn, A ^f   Dhejne, C ^g   Morel Journel, N ^h   Gooren, L J ⁱ  

^a HAJAP ^*  (France)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSIDAD DE LA LAGUNA   (Spain)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^f Universitats Frauenklinik   (Switzerland)

^g KAROLINSKA INSTITUTE   (Sweden)

^h UNIVERSITÉ DE LYON   (France)

ⁱ AndroConsult   (Thailand)

Author keywords

Cross sex hormones; Ethinyl oestradiol; Oestrogen; Transsexual; Venous thrombosis

Indexed keywords

ANTIANDROGEN; CYPROTERONE ACETATE; ESTROGEN; ETHINYLESTRADIOL; ORAL CONTRACEPTIVE AGENT; SEX HORMONE;

ARTICLE; CARDIOVASCULAR RISK; CHEMICAL STRUCTURE; ESTROGEN THERAPY; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; MAJOR SURGERY; MALE TO FEMALE TRANSSEXUAL; MOBILIZATION; POSTOPERATIVE COMPLICATION; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM; ADVERSE EFFECTS; FEMALE; MALE; TRANSSEXUALISM;

FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; TRANSSEXUALISM; VENOUS THROMBOEMBOLISM;

EID: 84890066528     PISSN: 03034569     EISSN: 14390272     Source Type: Journal    
DOI: 10.1111/and.12150     Document Type: Article

References (27)

1. Asscheman H, Gooren LJ, Eklund PL (1989) Mortality and morbidity in transsexual patients with cross-gender hormone treatment. Metabolism 38:869-873.
2. Asscheman H, Giltay EJ, Megens JA, de Ronde WP, van Trotsenburg MA, Gooren LJ (2011) A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. Eur J Endocrinol 164:635-642.
3. Becerra Fernandez A, De Luis Roman D, Piedrola Maroto G (1999) Morbilidad en pacientes transexuales con autotratamiento hormonal para cambiar de sexo. Med Clin (Barc) 113:481-483.
4. Canonico M, Plu-Bureau G, Lowe GD, Scarabin PY (2008) Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ 336:1227-1231.
5. De Cuypere G, T'Sjoen G, Beerten R, Selvaggi G, De Sutter P, Hoebeke P, Monstrey S, Vansteenwegen A, Rubens R (2005) Sexual and physical health after sex reassignment surgery. Arch Sex Behav 34:679-690.
6. Dittrich R, Binder H, Cupisti S, Hoffmann I, Beckmann MW, Mueller A (2005) Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist. Exp Clin Endocrinol Diabetes 113:586-592.
7. Gardner MJ, Altman DFG (1989) Statistics with Confidence. British Medical Journal, London.
8. Gooren LJ (2011) Clinical practice. Care of transsexual persons. N Engl J Med 364:1251-1257.
9. Gooren LJ, Giltay EJ, Bunck MC (2008) Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience. J Clin Endocrinol Metab 93:19-25.
10. Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, Gooren LJ, Meyer WJ 3rd, Spack NP, Tangpricha V, Montori VM (2009) Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 94:3132-3154.
11. Lehrman KL (1976) Pulmonary embolism in a transsexual man taking diethylstilbestrol. JAMA 235:532-533.
12. Lidegaard O, Nielsen LH, Skovlund CW, Skjeldestad FE, Lokkegaard E (2011) Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9. BMJ 343:d6423.
13. Lidegaard O, Lokkegaard E, Jensen A, Skovlund CW, Keiding N (2012) Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med 366:2257-2266.
14. deMarinis M, Arnett EN (1978) Cerebrovascular occlusion in a transsexual man taking mestranol. Arch Intern Med 138:1732-1733.
15. Olie V, Canonico M, Scarabin PY (2010) Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women. Curr Opin Hematol 17:457-463.
16. Ott J, Kaufmann U, Bentz EK, Huber JC, Tempfer CB (2010) Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy. Fertil Steril 93:1267-1272.
17. Palareti G, Cosmi B (2009) Bleeding with anticoagulation therapy - who is at risk, and how best to identify such patients. Thromb Haemost 102:268-278.
18. Prior JC, Vigna YM, Watson D (1989) Spironolactone with physiological female steroids for presurgical therapy of male-to-female transsexualism. Arch Sex Behav 18:49-57.
19. Schlatterer K, Yassouridis A, von Werder K, Poland D, Kemper J, Stalla GK (1998) A follow-up study for estimating the effectiveness of a cross-gender hormone substitution therapy on transsexual patients. Arch Sex Behav 27:475-492.
20. Seaman HE, Langley SE, Farmer RD, de Vries CS (2007) Venous thromboembolism and cyproterone acetate in men with prostate cancer: a study using the General Practice Research Database. BJU Int 99:1398-1403.
21. Sitruk-Ware R, Nath A (2013) Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills. Best Pract Res Clin Endocrinol Metab 27:13-24.
22. Sweetland S, Green J, Liu B, Berrington de Gonzalez A, Canonico M, Reeves G, Beral V (2009) Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ 339:b4583.
23. Toorians AW, Thomassen MC, Zweegman S, Magdeleyns EJ, Tans G, Gooren LJ, Rosing J (2003) Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people. J Clin Endocrinol Metab 88:5723-5729.
24. Van Kesteren PJ, Asscheman H, Megens JA, Gooren LJ (1997) Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clin Endocrinol (Oxf) 47:337-342.
25. Vehkavaara S, Silveira A, Hakala-Ala-Pietila T, Virkamaki A, Hovatta O, Hamsten A, Taskinen MR, Yki-Jarvinen H (2001) Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women. Thromb Haemost 85:619-625.
26. Wierckx K, Mueller S, Weyers S, Van Caenegem E, Roef G, Heylens G, T'Sjoen G (2012) Long-term evaluation of cross-sex hormone treatment in transsexual persons. J Sex Med 9:2641-2651.
27. Wilson R, Spiers A, Ewan J, Johnson P, Jenkins C, Carr S (2009) Effects of high dose oestrogen therapy on circulating inflammatory markers. Maturitas 62:281-286.